India faces a devastating snakebite crisis, with roughly 50,000 deaths annually, accounting for half the global total. A recent report reveals significant challenges in administering life-saving antivenom. Limited access, poor infrastructure, and insufficient training among healthcare workers are major hurdles. Delays in treatment often lead to severe complications, including amputations and mobility issues.

This crisis disproportionately affects poor, rural communities. The World Health Organization has classified snakebite envenoming as a "highest priority neglected tropical disease." India launched a National Action Plan in 2024 to halve snakebite deaths by 2030, focusing on better surveillance, improved antivenom availability, and public awareness.

Experts agree that implementation has been inconsistent. A major issue is the lack of specialized antivenom for many snake species. Currently, antivenom primarily targets the "big four" snakes, leaving victims of other poisonous species vulnerable. Addressing the crisis requires improved healthcare infrastructure and increased awareness.

Further complicating matters is the reliance on faith healers and local medicinal practices in rural areas. The development of region-specific antivenoms and improved reporting of snakebites are essential steps forward. The Karnataka state government's move to make snakebites a notifiable disease could improve data collection and facilitate better responses.